‘Barbie’ wins the summer box office, but fall looks gloomy — even with Taylor Swift

‘Barbie’ wins the summer box office, but fall looks gloomy — even with Taylor Swift


A scene from “Barbie.”

Courtesy: Warner Bros.

Hollywood bet big on blockbuster franchise sequels to revive its summer cinema business, but it was fresh fare like “Barbie” and “Oppenheimer” that fueled the industry’s haul of $4 billion, a 19% jump from last year.

Starting the first Friday in May and running through Labor Day weekend, the summer movie season, on average, represents 40% of all movie ticket sales for the year. Studios typically pad this part of the release calendar with superhero spectacles, franchise sequels and action-packed flicks in an effort to capture audience attention during the hottest months of the year.

Fall is looking gloomy, however.

Movie theaters are already contending with less content than previous years. Missing titles such as “Dune: Part Two” will exacerbate that issue. The industry got some good news in the form of Taylor Swift’s Era Tours concert film, arriving in theaters in October. Expectations are set high for its debut, with many box office analysts expecting a $100 million opening. Swift won’t be able to balance the scales by herself, though.

Still recovering from the pandemic, Hollywood has entered a chaotic period of recovery. As studios are desperately trying to lure moviegoers away from their couches, they are also contending with dual labor strikes that have limited their ability to market their slate.

Top summer movies of 2023, domestic

  • Warner Bros.’ “Barbie” — $612.3 million
  • Sony’s “Spider-Man: Across the Spider-Verse” — $381.2 million
  • Disney’s “Guardians of the Galaxy: Vol. 3” — $358.9 million
  • Universal’s “Oppenheimer” — $310.6 million
  • Disney’s “The Little Mermaid” — $298.1 million

Source: Comscore

Summertime gladness

Following pandemic-related shutdowns, Hollywood has fewer titles to offer up to theaters. This summer there were 10 fewer wide released films than in 2019, a nearly 24% decline. Still, the 2023 summer box office managed to only trail pre-pandemic levels by just 5.9%, or a little more than $200 million, according to data from Comscore.

“Perhaps the most notable aspect of the summer movie season of ’23 was its volatility,” said Paul Dergarabedian, senior media analyst at Comscore.

Costly franchise installments, which were supposed to tap into audience nostalgia, fell flat.

Paramount’s Tom Cruise vehicle “Mission: Impossible — Dead Reckoning Part One,” Warner Bros.′ DC Comics tentpole “The Flash,” Universal’s “Fast X” and Disney’s “Indiana Jones and the Dial of Destiny” all fell flat at the domestic box office. Each generated less than $200 million in the U.S. and Canada.

Instead, cinema patrons opted for original storytelling, leaning toward the bubblegum pink “Barbie” and dark and intense “Oppenheimer.”

“Barbie,” a partnership between Warner Bros. and Mattel, generated $612.3 million between its July 21 release and Labor Day, representing 15% of the total summer box office.

In addition to titles from major studios, the summer haul was fueled by ticket sales for “Sound of Freedom” from Angel Studios, which became a surprise hit with audiences. It has generated nearly $200 million since its July 4 release.

Fall pall

Timothee Chalamet and Rebecca Ferguson star in Denis Villeneuve’s adaptation of “Dune.”

Warner Bros.

The summer season also showed a growing desire from audiences for tickets to premium format showings, said Shawn Robbins, chief analyst at BoxOffice.com. He said the industry can learn a lot from the performances of titles like “Barbie,” particularly the appeal of grassroots communal experiences in cinemas.

“The caveat, however, is that the release calendar has thinned out slightly due to the ongoing strikes,” he said. “While this could create an opportunity for certain studios and films, it’s a headwind that nonetheless presents an increasing number of challenges for theater owners and audiences who don’t want to see more delays of movies they’re looking forward to.”

Over the longer term, it would become an increasing worry for next year as productions remain halted, Robbins added.

And it comes as the theater industry is reigniting, with overall box office from January through Labor Day up around 25% from last year.

However, it still lags from 2019 levels by 13%, and the fall movie season looks to be a tepid one, even with Swift’s concert movie on the calendar.

Already, films like Warner Bros. and Legendary Entertainment’s “Dune: Part Two” and Sony’s “Kraven the Hunter” and the “Ghostbusters: Afterlife” sequel have all departed for 2024 as writers and actors strike against studios.

Disclosure: NBCUniversal is the parent company of Universal and CNBC.



Source

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push
Business

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push

U.S. Senator Elizabeth Warren (D-MA) and Director of the United States Office of Management and Budget, Russell Vought. Kevin Mohatt | Kevin Lamarque | | Reuters Sen. Elizabeth Warren on Friday accused the acting head of the Consumer Financial Protection Bureau of undermining President Donald Trump’s stated push to make credit cards more affordable, according […]

Read More
Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More